A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancer.

Zhang, Weisan; Liu, Qian; Dong, Xifeng; Lei, Ping

Zhang, Weisan; Liu, Qian; Dong, Xifeng; Lei, Ping.

Afiliación

Zhang W; 1 Department of Geriatrics, 2 Tianjin Lung Cancer Institute, 3 Department of Hematology-Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Liu Q; 1 Department of Geriatrics, 2 Tianjin Lung Cancer Institute, 3 Department of Hematology-Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Dong X; 1 Department of Geriatrics, 2 Tianjin Lung Cancer Institute, 3 Department of Hematology-Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Lei P; 1 Department of Geriatrics, 2 Tianjin Lung Cancer Institute, 3 Department of Hematology-Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.

J Thorac Dis ; 7(3): 478-85, 2015 Mar.

Article en En | MEDLINE | ID: mdl-25922728

Palabras clave

Non-small cell lung cancer (NSCLC); continuous hyperfractionated accelerated radiotherapy (CHART); continuous hyperfractionated accelerated radiotherapy weekend less (CHARTWEL); hyperfractionated radiotherapy (HRT)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: J Thorac Dis Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google